InvestorsHub Logo

BioTechMaven

05/15/17 8:56 AM

#182020 RE: mdphd2008 #182011

The fast approaching milestones that are important to me:

1. July 13: topline data reveal for lead IBD drug.

2. 3q17: interim data for Prurisol for psoriasis.

Both of these indications (IBD and Psoriasis) are huge deal movers.

Again, expecting a partnership or buyout this year, and a dramatic share price move...

Good luck to all.